Title | The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase. |
Publication Type | Journal Article |
Year of Publication | 1999 |
Authors | Ball, H J., Melnick A, Shaknovich R, Kohanski R A., and Licht J D. |
Journal | Nucleic Acids Res |
Volume | 27 |
Issue | 20 |
Pagination | 4106-13 |
Date Published | 1999 Oct 15 |
ISSN | 1362-4962 |
Keywords | Animals, Base Sequence, Binding Sites, CDC2 Protein Kinase, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 17, COS Cells, DNA, DNA-Binding Proteins, Humans, Kruppel-Like Transcription Factors, Macromolecular Substances, Molecular Sequence Data, Molecular Weight, Promyelocytic Leukemia Zinc Finger Protein, Transcription Factors, Translocation, Genetic, Tumor Cells, Cultured, Zinc Fingers |
Abstract | <p>A binding site selection from a CpG island library for the promyelocytic leukemia zinc finger protein (PLZF) identified two high affinity PLZF binding sites. These sequences also bound RARalpha/PLZF, a fusion protein formed in chromosomal translocation t(11;17)(q23;q21) associated with acute promyelocytic leukemia. PLZF bound DNA as a slowly migrating complex with an estimated mol. wt of 600 kDa whose formation was dependent on the POZ/dimerization domain of PLZF. The PLZF-DNA complex was unable to form in the presence of cdc2 antibodies. A PLZF-cdc2 interaction was further demonstrated by co-immunoprecipitation and a biotin-streptavidin pull-down assay. PLZF is a phosphoprotein and immunoprecipi-tates with a cdc2-like kinase activity. The PLZF-DNA complex was abolished with the addition of a phosphatase. These studies suggest that the activity of PLZF, a regulator of the cell cycle, may be modulated by cell cycle proteins. RARalpha/PLZF did not complex with cdc2, this potentially contributing to its aberrant transcriptional properties and potential role in leukemo-genesis.</p> |
DOI | 10.1093/nar/27.20.4106 |
Alternate Journal | Nucleic Acids Res |
PubMed ID | 10497277 |
PubMed Central ID | PMC148680 |
Grant List | CA59936 / CA / NCI NIH HHS / United States K08 CA73762 / CA / NCI NIH HHS / United States |